ClinicalTrials.Veeva

Menu

Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.

T

Tongji University

Status

Conditions

HDFN

Treatments

Other: zimin Lu,Guo Sa

Study type

Expanded Access

Funder types

Other

Identifiers

NCT02969174
ShangjiTongjiHsxk

Details and patient eligibility

About

To establish a genotyping and extraction technology of non invasive prenatal diagnosis for fetal blood group genotype from cell-free fetal DNA in peripheral blood of pregnant women.

To achieve prenatal accurate identification of fetal blood group genotypes,and provide credible theoretical evidence for the prenatal diagnosis and treatment of hemolytic disease of newborn (HDN).

Full description

Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.

Sex

All

Ages

12 to 38 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

blood samples of pregnant couples,gender/nation/region is unlimited.

Exclusion criteria

adipose or hemolytic samples,overdue samples,unidentified samples

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems